Association of pesticide exposure, vaccination response, and interleukin-1 gene polymorphisms
暂无分享,去创建一个
H. van Loveren | S. Fustinoni | S. Birindelli | E. Corsini | J. Liesivuori | M. Barańska | L. van Amelsvoort
[1] S. Fustinoni,et al. Immunomodulatory effects of the fungicide Mancozeb in agricultural workers. , 2005, Toxicology and applied pharmacology.
[2] S. Birindelli,et al. Low level exposure to chemicals and immune system. , 2005, Toxicology and applied pharmacology.
[3] S. Fustinoni,et al. Application of gas chromatography-mass spectrometry for the determination of urinary ethylenethiourea in humans. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[4] H. van Loveren,et al. Cytokine Polymorphisms Play a Role in Susceptibility to Ultraviolet B-Induced Modulation of Immune Responses after Hepatitis B Vaccination1 , 2003, The Journal of Immunology.
[5] H. van Loveren,et al. IL-1beta gene polymorphisms influence hepatitis B vaccination. , 2002, Vaccine.
[6] S. Nakae,et al. Interleukin‐1β, but not interleukin‐1α, is required for T‐cell‐dependent antibody production , 2001 .
[7] S. Nakae,et al. IL-1 Enhances T Cell-Dependent Antibody Production Through Induction of CD40 Ligand and OX40 on T Cells1 , 2001, The Journal of Immunology.
[8] S. Socransky,et al. Effect of the interleukin-1 genotype on monocyte IL-1beta expression in subjects with adult periodontitis. , 2000, Journal of periodontal research.
[9] J. Pankow,et al. Interleukin-1 genotypes and the association between periodontitis and cardiovascular disease. , 1999, Journal of periodontal research.
[10] F. Ennis,et al. IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens. , 1999, Journal of immunology.
[11] P. Miossec,et al. Possible genetic association between interleukin-1alpha gene polymorphism and the severity of chronic polyarthritis. , 1999, European cytokine network.
[12] P. Roux‐Lombard. The interleukin-1 family. , 1999, European cytokine network.
[13] C. Dinarello,et al. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction. , 1998, Arthritis and rheumatism.
[14] A. Cox,et al. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment , 1996, Human Genetics.
[15] J. Blackwell,et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis , 1995, The Journal of experimental medicine.
[16] F. Pociot,et al. A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro , 1992 .
[17] T. Galloway,et al. Immunotoxicity of Organophosphorous Pesticides , 2003, Ecotoxicology.
[18] S. Nakae,et al. Interleukin-1 beta, but not interleukin-1 alpha, is required for T-cell-dependent antibody production. , 2001, Immunology.
[19] F. Pociot,et al. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. , 1992, European journal of clinical investigation.